Clopidogrel Pharmacogenomics Project
NCT01097343
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Disease Susceptibility
Interventions
DRUG:
clopidogrel 75 mg
DRUG:
Clopidogrel 150 mg
Sponsor
University of North Carolina, Chapel Hill